Janssen receives two u.s. fda approvals for simponi aria ® (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis
SIMPONI ARIA ® is the Only Fully-Human Anti-TNF-alpha Infused Therapy Now Approved
for Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
More News: Ankylosing Spondylitis | Arthritis | Pharmaceuticals | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology